Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia

NCT07270432 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Hyperplasia, Benign

Interventions

DRUG: Product DNN.65.21.005
DRUG: Combodart®

Sponsor

Ache Laboratorios Farmaceuticos S.A.